RANTES production by cytokine-stimulated nasal fibroblasts: Its inhibition by glucocorticoids

International Archives of Allergy and Immunology

Volumn 117, Issue 1, 1998, Pages 60-67

  Meyer, Jens E ^a   Berner, Ina ^a   Teran, Luis M ^a   Bartels, Joachim ^a   Sticherling, Michael ^a   Schröder, Jens M ^a   Maune, Steffen ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Corticosteroids; Fibroblasts, nasal; Polyposis, nasal; RANTES

Indexed keywords

BETAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID; HYDROCORTISONE; INTERLEUKIN 1BETA; MESSENGER RNA; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHEMOTAXIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

CELLS, CULTURED; CYTOKINES; EOSINOPHILS; FIBROBLASTS; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; NASAL MUCOSA; RANTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031689580     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023991     Document Type: Article

References (27)

1. Flavahan NA, Slifman NR, Gleich GJ, Vanhoutte PM: Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium. Am Rev Respir Dis 1988;138:685-688.
2. Hastie AT, Loegering DA, Gleich GJ: The effect of purified human eosinophil major cationic protein on mammalian ciliary activity. Am Rev Respir Dis 1987;135:685-688.
3. Wong DT, Weller PF, Galli SJ, et al: Human eosinophils express transforming growth factor a. J Exp Med 1990;172:673-681.
4. Ohno I, Lea RG, Flanders KC, et al: Eosinophils in chronically inflamed human upper airway tissue express transforming growth factor b1 gene (TGFb1). J Clin Invest 1992;89: 1662-1668.
5. Rubbia-Brandt L, Sappino A, Gabbiani G: Locally applied GM-CSF induces the accumulation of a-smooth muscle actin containing myofibroblasts. Virchows Arch 1991;60:73-82.
6. Wagenmann M, Dater I, Rudack I, Ganzer U, Bachert C: IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997;99:837-842.
7. Ponath PD, Qin S, Ringier DJ, et al: Cloning of the human eosinophil chemoattractant, eotaxin. J Clin Invest 1996;97:604-612.
8. Beck LA, Stellato C, Beall LD, et al: Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps. J Allergy Clin Immunol 1996;98:766-780.
9. Teran LM, Park H, Djukanovic R, Roberts K, Holgate ST: Cultured nasal polyps from nonatopic and atopic patients released RANTES spontaneously and after stimulation with phytohemagglutinin. J Allergy Clin Immunol 1997;100:499-504.
10. Schall TJ: Biology of the RANTES/SIS cytokine family. Cytokine 1991;3:165-183.
11. Teran LM, Davies DE: The chemokines: Their potential role in allergic inflammation. Clin Exp Allergy 1996;126:1005-1019.
12. Meurer R, Van Riper G, Feeney W, et al: Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8. J Exp Med 1993;178:1913-1921.
13. Hamilos DL, Leung DYM, Wood R, et al: Eosinophil infiltration in non-allergic chronic hyperplastic sinusitis with nasal polypsis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha. Am J Respir Cell Mol Biol 1996; 15:443-450.
14. Umbach B, Hennebach U: Changes in connective tissue metabolism in fibroblasts from nasal polyps. HNO 1994;42:344-349.
15. Xing Z, Jordana M, Braciak T, Ohtoshi T, Gauldie J: Lypopolysaccaride induces expression of granulocyte macrophage colony-stimulating factor, interleukin-8, and interleukin-6 in human nasal, but not lung, fibroblasts: Evidence for heterogeneity within the respiratory tract. Am Respir Cell Mol Biol 1993;9:255-263.
16. Maune S, Berner I, Sticherling M, Kulke R, Bartels J, Schröder J-M: Fibroblasts but not nasal epithelial cells obtained from human nasal mucosa produce the chemokine RANTES. Rhinology 1997;34:210-214.
17. Kameyoshi YA, Dorschener AI, Mallet E, et al: Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992;176:587-592.
18. Sticherling M, Kuepper M, Koltrowitz F, et al: Detection of chemokine RANTES in cytokine-stimulated human dermal fibroblasts. J Invest Dermatol 1995;105:585-591.
19. Devergne O, Marfaing Koka A, Schall TJ, et al: Production of the RANTES chemokine in delayed-type hypersensitivity reactions: Involvement of macrophages and endothelial cells. J Exp Med 1994;179:1689-1694.
20. Schall TJ, Jongstra J, Dyer BJ, et al: A human T-cell specific molecule is a member of a new gene family. J Immunol 1988;141:1018-1025.
21. Chihara J, Oyamada H, Yamada H, et al: Expression of mRNA for RANTES in human eosinophils. Int Arch Allergy Immunol 1895; 114(suppl 1):33-35.
22. Teran LM, Noso N, Carroll MP, et al: Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES in asthmatic airways. J Immunol 1996;157:1806-1812.
23. Bradding P, Mediwake R, Feather IH, et al: TNF-alpha is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. Clin Exp Allergy 1995;25:406-415.
24. Sim TC, Reece LM, Hilsmeier KA, Grant JA, Alam R: Secretion of chemokines and other cytokines in allergen-induced nasal responses: Inhibition by topical steroid treatment. Am J Respir Crit Care Med 1995;152:927-933.
25. Kwon OJ, Joes OP, Robbins RA, Schall TJ, Williams TJ, Barnes PJ: Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am J Respir Cell Mol Biol 1995; 12:488-496.
26. Stellato C, Beck LA, Gorgone GA, et al: Expression of the chemokine RANTES by a human bronchial epithelial cell line: Modulation by cytokines and glucocorticoids. J Immunol 1995;155:410-418.
27. Kuschinsky G, Lüllmann H, Peters T: Kurzes Lehrbuch der Pharmakologie und Toxikologie. Stuttgart, Thieme, 1978, pp 277-278.